Announced Thu, 3 Sept · 23:50 IST
Board approves 51% stakes in two diagnostics firms and doubles authorised capital
ONEGLOBAL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-0.4%1-day move
₹527.15
prior close
₹547.80
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.0-0.0-0.1-0.1-0.4+0.9+2.6+3.4+2.8-1.1————
Up moveDown movePending
AI summary
Board approved acquiring 51 percent stakes each in Matrix Labs Diagnocare (turnover Rs 171.30 Cr) and Matrix Labs Private Limited (turnover Rs 8.92 Cr) via share swap, allotting 7,15,040 equity shares at Rs 553 each (premium Rs 543) worth about Rs 39.54 Cr. Also doubled authorised capital from Rs 25.05 Cr to Rs 50 Cr. New statutory and internal auditors appointed. 34th AGM set for 29 September 2026.
Likely market impact
Share dilution of about 3.5% to selling shareholders. Move into diagnostics diversifies business but shifts focus from current operations.